James M Reuben
Overview
Explore the profile of James M Reuben including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
136
Citations
6906
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Le Du F, Fujii T, Kida K, Davis D, Park M, Liu D, et al.
PLoS One
. 2020 Mar;
15(3):e0229903.
PMID: 32214335
Background: Tumor cells with a mesenchymal phenotype and/or cancer stem-like cells (CSCs) are known to contribute to metastasis and drug resistance. Circulating tumor cells (CTCs) undergoing epithelial-mesenchymal transition (EMT) and...
22.
Goldstein L, Perez R, Yardley D, Han L, Reuben J, Gao H, et al.
Breast Cancer Res
. 2020 Jan;
22(1):4.
PMID: 31924241
Background: Cancer stem cells (CSCs) are purported to be responsible for tumor initiation, treatment resistance, disease recurrence, and metastasis. CXCR1, one of the receptors for CXCL8, was identified on breast...
23.
Ueno N, Tahara R, Fujii T, Reuben J, Gao H, Saigal B, et al.
Cancer Med
. 2019 Dec;
9(3):1025-1032.
PMID: 31849202
Background: Radium-223 dichloride (Ra-223) is a targeted alpha therapy that induces localized cytotoxicity in bone metastases. We evaluated the efficacy and safety of Ra-223 plus hormonal therapy in hormone receptor-positive...
24.
De Giorgi U, Mego M, Scarpi E, Giordano A, Giuliano M, Valero V, et al.
Ther Adv Med Oncol
. 2019 Aug;
11:1758835919866065.
PMID: 31452692
Background: We retrospectively evaluated the correlation between a baseline measurement of circulating tumor cells (CTCs) and inflammation-based scores in patients with metastatic breast cancer (MBC). Methods: The optimal value of...
25.
Yap K, Cohen E, Reuben J, Khoury J
Curr Hematol Malig Rep
. 2019 Aug;
14(5):353-357.
PMID: 31364034
Purpose Of Review: Circulating tumor cells represent rare events in the peripheral blood of patients with cancer that can provide insight into tumor biology. CTC enumeration, isolation, and analysis represent...
26.
Cohen E, Fouad T, Lee B, Arun B, Liu D, Tin S, et al.
Breast Cancer Res Treat
. 2019 May;
176(3):545-556.
PMID: 31054033
Purpose: The carbohydrate sialyl Lewis (sLe) mediates cell adhesion, is critical in the normal function of immune cells, and is frequently over-expressed on cancer cells. We assessed the association, differential...
27.
Reddy S, Reuben A, Barua S, Jiang H, Zhang S, Wang L, et al.
Cancer Immunol Res
. 2019 May;
7(6):1025-1035.
PMID: 31043414
Our understanding is limited concerning the tumor immune microenvironment of inflammatory breast cancer (IBC), an aggressive form of primary cancer with low rates of pathologic complete response to current neoadjuvant...
28.
Mego M, Karaba M, Minarik G, Benca J, Silvia J, Sedlackova T, et al.
Anticancer Res
. 2019 Apr;
39(4):1829-1837.
PMID: 30952723
Background/aim: Circulating tumor cells (CTCs) comprise a heterogeneous population of cancer cells with different clinical and biological value. The aim of this study was to evaluate the prognostic value of...
29.
Harano K, Wang Y, Lim B, Seitz R, Morris S, Bailey D, et al.
PLoS One
. 2018 Oct;
13(10):e0204513.
PMID: 30312311
In patients with triple-negative breast cancer (TNBC), tumor-infiltrating lymphocytes (TILs) are associated with improved survival. Lehmann et al. identified 4 molecular subtypes of TNBC [basal-like (BL) 1, BL2, mesenchymal (M),...
30.
Fouad T, Ueno N, Yu R, Ensor J, Alvarez R, Krishnamurthy S, et al.
PLoS One
. 2018 Sep;
13(9):e0204372.
PMID: 30248155
Background: To date, studies on inflammatory breast cancer (IBC) lack comprehensive epidemiological data. We analyzed detailed prospectively collected clinical and epidemiological data from the IBC Registry at The University of...